β‐Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2 / AMPK / PINK1 /Parkin pathway
Aging Cell · 2024
DOI: 10.1111/acel.14294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Huangming Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Chondrocytes, Mitophagy, Osteoarthritis, Protein Kinases. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Medical Youth Tip-Top Talent to Panghu zhou, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Osteoarthritis (OA) is widely recognized as the prevailing joint disease associated with aging. The ketogenic diet (KD) has been postulated to impede the advancement of various inflammatory ailments. β‐Hydroxybutyrate (βOHB), a prominent constituent of ketone bodies, has recently been proposed to possess crucial signaling capabilities. In this study, we propose to explore the role and mechanism of βOHB in OA. Tissue staining and inflammatory factor assay were employed to evaluate the impacts of KD and βOHB on OA rats. The oxidative stress conditions in chondrocytes were induced using tert‐butyl hydroperoxide (TBHP). The mechanisms were determined using the siRNA of hydroxycarboxylic acid receptor 2 (HCAR2), the antagonist of adenosine monophosphate‐activated protein kinase (AMPK), and the inhibitor of mitophagy. The administration of KD demonstrated a reduction in pathological damage to cartilage, as well as a decrease in plasma levels of inflammatory factors. Furthermore, it resulted in an increase in the concentration of βOHB in the blood and synovial fluid. In vitro experiments showed that βOHB facilitated mitophagy and adenosine triphosphate production. Besides, βOHB mitigated chondrocyte senescence, inflammatory factors secretion, extracellular matrix degradation, and apoptosis induced by TBHP. Subsequent investigations indicated that the protective effects of βOHB were no longer observed following the knockdown of HCAR2, the antagonist of AMPK, or the inhibitor of mitophagy. Moreover, in vivo studies suggested that βOHB played a protective role by targeting the HCAR2‐AMPK‐PINK1 axis. In conclusion, βOHB enhanced chondrocyte mitophagy through the HCAR2/AMPK/PINK1/Parkin pathway, offering a potential therapeutic approach for the treatment of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Panghu Zhou
Förderung
- National Natural Science Foundation of China
- Hubei Medical Youth Tip-Top Talent to Panghu zhou
- Fundamental Research Funds for the Central Universities
- Wuhan University Education and Development Foundation
- Cross-Innovation Talent Program of Renmin Hospital of Wuhan University
Zitieren
APA
Zhuang, H., Ren, X., Zhang, Y., Li, H., & Zhou, P. (2024). β‐Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2 / AMPK / PINK1 /Parkin pathway. Aging Cell. https://doi.org/10.1111/acel.14294
Vancouver
Zhuang H, Ren X, Zhang Y, Li H, Zhou P. β‐Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2 / AMPK / PINK1 /Parkin pathway. Aging Cell. 2024. doi:10.1111/acel.14294
BibTeX
@article{Zhuang2024,
author = {Zhuang, Huangming and Ren, Xunshan and Zhang, Yuelong and Li, Huajie and Zhou, Panghu},
title = {β‐Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2 / AMPK / PINK1 /Parkin pathway},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14294}
}
EUVIMED